PWAM
CRL icon

Park West Asset Management’s Charles River Laboratories CRL Stock Holding History

Park West Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.34M Sell
41,200
-3,600
-8% -$641K 0.64% 41
2026
Q1 		$7.73M Buy
+44,800
New +$8.31M 0.66% 39

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Park West Asset Management's CRL Position: Q2 2026 in Review

Park West Asset Management reduced its Charles River Laboratories (CRL) stake by 8% in Q2 2026, selling an estimated $641K and leaving 41,200 shares worth $9.34M. The position accounts for 0.64% of the portfolio, ranked #41.

Park West Asset Management first reported a position in CRL in Q1 2026 and has held it in 2 quarters since. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Park West Asset Management held 41,200 shares of Charles River Laboratories worth $9.34M as of Q2 2026.
  • Park West Asset Management sold 3,600 Charles River Laboratories shares in Q2 2026, an estimated $641K.
  • Charles River Laboratories made up 0.64% of Park West Asset Management's portfolio in Q2 2026, its #41 holding.
  • Park West Asset Management first reported a position in Charles River Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Park West Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.